Disease associated variation - GWASdb |
Chr | Pos | SNP ID(dbSNP 142) | Ref | Alt | Ori SNP ID | P-value | Drug Name | Drug Anno | GWAS Trait | HPO ID | DO ID | AA | Type | Trait or Drug |
18 | 55810733 | rs549476 | A | G | rs549476 | 3.00E-06 | DEXTROAMPHETAMINE | PLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONE | Response to amphetamines | HPOID:0000707 | DOID:670 | A | intron | GWASdb_drug |
18 | 55828612 | rs8088164 | T | C | rs8088164 | 5.33E-05 | ALDOSTERONE | BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | T | intron | GWASdb_drug |
18 | 55910523 | rs158856 | C | T | rs158856 | 7.00E-06 | CAFFEINE | RECEPTOR, ADENOSINE A2A|PRIMA1 PROTEIN, HUMAN|NERVE TISSUE PROTEINS|MEMBRANE PROTEINS | Insomnia (caffeine-induced) | HPOID:0100785 | DOID:8611 | C | intron | GWASdb_drug |
18 | 55915325 | rs2288772 | G | A | rs2288772 | 1.00E-04 | TOPIRAMATE|FRUCTOSE | ANTICONVULSANTS | Cognitive impairment induced by topiramate | HPOID:0100543 | DOID:1561 | A | intron | GWASdb_drug |
18 | 55938204 | rs7230600 | G | A | rs7230600 | 9.14E-04 | ALDOSTERONE | BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | A | intron | GWASdb_drug |
18 | 55941906 | rs4941373 | G | C | rs4941373 | 8.50E-06 | TESTOSTERONE | LIN-28 PROTEIN, HUMAN|BIOLOGICAL MARKERS|RNA-BINDING PROTEINS | Digit length ratio | HPOID:0000818 | DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287 | G | intron | GWASdb_drug |
18 | 55957987 | rs4058295 | C | A | rs4058295 | 8.30E-06 | TESTOSTERONE | LIN-28 PROTEIN, HUMAN|BIOLOGICAL MARKERS|RNA-BINDING PROTEINS | Digit length ratio | HPOID:0000818 | DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287 | C | intron | GWASdb_drug |
18 | 55983364 | rs2288775 | A | G | rs2288775 | 5.50E-06 | TESTOSTERONE | LIN-28 PROTEIN, HUMAN|BIOLOGICAL MARKERS|RNA-BINDING PROTEINS | Digit length ratio | HPOID:0000818 | DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287 | G | intron | GWASdb_drug |
18 | 56041732 | rs7242150 | T | G | rs7242150 | 8.10E-04 | ATORVASTATIN | SERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASES | Response to statin treatment (atorvastatin), change in cholesterol levels | HPOID:0001626 | DOID:1287 | T | intron | GWASdb_drug |
18 | 55720220 | rs8097619 | C | T | rs8097619 | 6.33E-04 | | | Insulin resistance | HPOID:0000855 | DOID:9352 | T | intron | GWASdb_trait |
18 | 55721004 | rs9989622 | C | G | rs9989622 | 9.89E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | G | intron | GWASdb_trait |
18 | 55721004 | rs9989622 | C | G | rs9989622 | 6.89E-04 | | | Insulin resistance | HPOID:0000855 | DOID:9352 | G | intron | GWASdb_trait |
18 | 55775343 | rs1787777 | T | C | rs1787777 | 6.11E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | C | intron | GWASdb_trait |
18 | 55783497 | rs529445 | C | A | rs529445 | 3.00E-06 | | | Amyotrophic lateral sclerosis (sporadic) | HPOID:0007354 | DOID:332 | C | intron | GWASdb_trait |
18 | 55784763 | rs554192 | A | G | rs554192 | 2.24E-04 | | | Premature ovarian failure | HPOID:0008209 | DOID:5426 | T | intron | GWASdb_trait |
18 | 55810733 | rs549476 | A | G | rs549476 | 3.00E-06 | | | Response to amphetamines | HPOID:0000707 | DOID:670 | A | intron | GWASdb_trait |
18 | 55811058 | rs878396 | G | A | rs878396 | 3.85E-05 | | | Atopy | HPOID:0001047 | DOID:0060056 | G | intron | GWASdb_trait |
18 | 55828612 | rs8088164 | T | C | rs8088164 | 5.33E-05 | | | Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) | HPOID:0011025 | DOID:10763 | T | intron | GWASdb_trait |
18 | 55903021 | rs158865 | C | T | rs158865 | 1.97E-05 | | | Crohn's disease | HPOID:0100280 | DOID:8778 | T | intron | GWASdb_trait |
18 | 55903721 | rs158862 | C | T | rs158862 | 5.71E-04 | | | Multiple complex diseases | HPOID:0000118 | NA | C | intron | GWASdb_trait |
18 | 55909630 | rs17064520 | C | T | rs17064520 | 3.22E-07 | | | Asthma | HPOID:0002099 | DOID:2841 | C | intron | GWASdb_trait |
18 | 55910523 | rs158856 | C | T | rs158856 | 7.00E-06 | | | Insomnia (caffeine-induced) | HPOID:0100785 | DOID:8611 | C | intron | GWASdb_trait |
18 | 55912732 | rs646509 | A | C | rs646509 | 1.20E-16 | | | Health and aging, CVD and cancer age of onset | HPOID:0002664|HPOID:0001626 | DOID:1287|DOID:162 | A | missense | GWASdb_trait |
18 | 55912732 | rs646509 | A | C | rs646509 | 2.50E-34 | | | Health and aging, CVD and cancer age of onset | HPOID:0002664|HPOID:0001626 | DOID:1287|DOID:162 | A | missense | GWASdb_trait |
18 | 55912732 | rs646509 | A | C | rs646509 | 2.60E-07 | | | Health and aging, CVD and cancer age of onset | HPOID:0002664|HPOID:0001626 | DOID:1287|DOID:162 | A | missense | GWASdb_trait |
18 | 55912732 | rs646509 | A | C | rs646509 | 2.70E-47 | | | Health and aging, CVD and cancer age of onset | HPOID:0002664|HPOID:0001626 | DOID:1287|DOID:162 | A | missense | GWASdb_trait |
18 | 55915325 | rs2288772 | G | A | rs2288772 | 1.00E-04 | | | Cognitive impairment induced by topiramate | HPOID:0100543 | DOID:1561 | A | intron | GWASdb_trait |
18 | 55936104 | rs1453082 | G | T | rs1453082 | 2.03E-05 | | | Endometrial cancer | HPOID:0012114 | DOID:1380 | C | intron | GWASdb_trait |
18 | 55936104 | rs1453082 | G | T | rs1453082 | 6.61E-05 | | | Endometrial cancer | HPOID:0012114 | DOID:1380 | C | intron | GWASdb_trait |
18 | 55936104 | rs1453082 | G | T | rs1453082 | 8.91E-05 | | | Endometrial cancer | HPOID:0012114 | DOID:1380 | C | intron | GWASdb_trait |
18 | 55937757 | rs12604734 | T | C | rs12604734 | 3.50E-05 | | | Diabetic retinopathy | HPOID:0000819|HPOID:0000488 | DOID:8947 | T | intron | GWASdb_trait |
18 | 55941906 | rs4941373 | G | C | rs4941373 | 8.50E-06 | | | Digit length ratio | HPOID:0000818 | DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287 | G | intron | GWASdb_trait |
18 | 55957987 | rs4058295 | C | A | rs4058295 | 8.30E-06 | | | Digit length ratio | HPOID:0000818 | DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287 | C | intron | GWASdb_trait |
18 | 55959751 | rs9952789 | G | C | rs9952789 | 9.00E-05 | | | Diabetic retinopathy | HPOID:0000819|HPOID:0000488 | DOID:8947 | G | intron | GWASdb_trait |
18 | 55983364 | rs2288775 | A | G | rs2288775 | 5.50E-06 | | | Digit length ratio | HPOID:0000818 | DOID:12849|DOID:1094|DOID:15|DOID:9970|DOID:9352|DOID:1287 | G | intron | GWASdb_trait |
18 | 55988294 | rs7243164 | G | A | rs7243164 | 1.65E-04 | | | Type 2 diabetes | HPOID:0005978 | DOID:9352 | G | intron | GWASdb_trait |
18 | 55991546 | rs10503022 | T | C | rs10503022 | 6.10E-05 | | | Diabetic retinopathy | HPOID:0000819|HPOID:0000488 | DOID:8947 | T | intron | GWASdb_trait |
18 | 55995721 | rs4058287 | A | G | rs4058287 | 9.29E-06 | | | Nephrolithiasis | HPOID:0000787 | DOID:585 | A,G | intron | GWASdb_trait |
18 | 56009604 | rs12454023 | C | T | rs12454023 | 8.00E-07 | | | Migraine with aura | HPOID:0002077 | DOID:10024 | C | intron | GWASdb_trait |
18 | 56009604 | rs12454023 | C | T | rs12454023 | 8.66E-04 | | | Migraine - clinic-based | HPOID:0002076 | DOID:6364 | C | intron | GWASdb_trait |
18 | 56041732 | rs7242150 | T | G | rs7242150 | 8.10E-04 | | | Response to statin treatment (atorvastatin), change in cholesterol levels | HPOID:0001626 | DOID:1287 | T | intron | GWASdb_trait |
18 | 56051135 | rs8098336 | T | C | rs8098336 | 7.13E-05 | | | Cognitive test performance | HPOID:0100543 | DOID:1561 | T | intron | GWASdb_trait |
18 | 56063153 | rs6566965 | C | T | rs6566965 | 3.34E-05 | | | Cognitive test performance | HPOID:0100543 | DOID:1561 | C | intron | GWASdb_trait |